These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32900537)

  • 1. RE: Botulinum toxin in the management of temporomandibular disorders: a systematic review.
    Hsing LC; Ilankovan V
    Br J Oral Maxillofac Surg; 2020 Nov; 58(9):1213-1214. PubMed ID: 32900537
    [No Abstract]   [Full Text] [Related]  

  • 2. [Botulinum toxin A: analgesic treatment for temporomandibular joint disorders].
    Denglehem C; Maes JM; Raoul G; Ferri J
    Rev Stomatol Chir Maxillofac; 2012 Feb; 113(1):27-31. PubMed ID: 22240328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of temporomandibular disorders with botulinum toxin.
    Schwartz M; Freund B
    Clin J Pain; 2002; 18(6 Suppl):S198-203. PubMed ID: 12569969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mechanism of the Beneficial Effect of Botulinum Toxin Type a Used in the Treatment of Temporomandibular Joints Dysfunction.
    Malgorzata P; Piotr C; Edward K
    Mini Rev Med Chem; 2017; 17(5):445-450. PubMed ID: 27151142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
    Chen YW; Chiu YW; Chen CY; Chuang SK
    Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of semiconductor laser therapy combined with botulinum toxin A type injection in treatment of temporomandibular disorders].
    Jiang MY; You QL
    Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):758-761. PubMed ID: 28275807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenic temporomandibular joint dislocation treated with botulinum toxin: report of 4 cases.
    Vázquez Bouso O; Forteza González G; Mommsen J; Grau VG; Rodríguez Fernández J; Mateos Micas M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e33-7. PubMed ID: 20219583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on: Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study, by Ernberg, Hedenberg-Magnusson, List, and Svensson.
    Janal MN; Raphael KG
    Pain; 2011 Sep; 152(9):2186-2187. PubMed ID: 21737201
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin.
    Daelen B; Thorwirth V; Koch A
    Int J Oral Maxillofac Surg; 1997 Dec; 26(6):458-60. PubMed ID: 9418151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Aspects of the Use of Botulinum Toxin Type A in the Treatment of Dysfunction of the Masticatory System.
    Bogucki ZA; Kownacka M
    Adv Clin Exp Med; 2016; 25(3):569-73. PubMed ID: 27629747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct infiltration of botulinum toxin into the pterygoid lateral muscle for repositioning of the disc during arthroscopy of the temporomandibular joint.
    Martín-Granizo R; Maniegas L; Colorado L; Millon-Cruz A; de Pedro M
    Br J Oral Maxillofac Surg; 2018 Oct; 56(8):769-771. PubMed ID: 30098840
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint.
    Fu KY; Chen HM; Sun ZP; Zhang ZK; Ma XC
    Br J Oral Maxillofac Surg; 2010 Jun; 48(4):281-4. PubMed ID: 19665263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.
    Kurtoglu C; Gur OH; Kurkcu M; Sertdemir Y; Guler-Uysal F; Uysal H
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1644-51. PubMed ID: 18634953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent TMJ Dislocation Managed with Botulinum Toxin Type A Injections in a Pediatric Patient.
    Stark TR; Perez CV; Okeson JP
    Pediatr Dent; 2015; 37(1):65-9. PubMed ID: 25685976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botox: the poison that heals.
    Khanna S; Jain S
    Int Dent J; 2006 Dec; 56(6):356-8. PubMed ID: 17243469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of botulinum toxin-a in the treatment of muscular temporomandibular joint disorders.
    Sipahi Calis A; Colakoglu Z; Gunbay S
    J Stomatol Oral Maxillofac Surg; 2019 Sep; 120(4):322-325. PubMed ID: 30807862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable Agents Versus Surgery for Recurrent Temporomandibular Joint Dislocation.
    Renapurkar SK; Laskin DM
    Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):343-349. PubMed ID: 29866448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A.
    Freund BJ; Schwartz M
    Headache; 2002; 42(10):1033-7. PubMed ID: 12453036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BTX-A for persistent myofascial TMD pain: interpreting a small clinical trial with negative results.
    Nixdorf DR
    Pain; 2011 Sep; 152(9):1944-1945. PubMed ID: 21641114
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin used to treat recurrent dislocation of the temporomandibular joint in a patient with osteoporosis.
    Oztel M; Bilski WM; Bilski A
    Br J Oral Maxillofac Surg; 2017 Jan; 55(1):e1-e2. PubMed ID: 27256802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.